In conclusion, we found an unexpected nuclear localization of DLK1 in hypoxic glioma cells, and demonstrated that a C-terminal fragment of DLK1 has signaling activity resulting in altered p53 and PI3K pathway activation (Fig. 8g). Here, TP53 is linked to central nervous system cancer.